Editor's Choice
M-A: Evaluating the association between LDL Cholesterol reduction and relative and absolute effects of statin treatment.
15 Mar, 2022 | 10:04h | UTCEvaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary from the author: Benefits of statins may have been overstated – new study – The Conversation
Commentary on Twitter
Our study in @JAMAInternalMed asked 2 questions 1. Is reducing one’s ‘bad’ cholesterol was associated with a proportional reduction in death, heart attack and stroke? 2. What's the absolute reduction in risk from taking statins? https://t.co/Zwh7LmUD0e
— Dr Paula Byrne (@pbyrne82) March 14, 2022
Review | Resistance exercise as a treatment for sarcopenia: prescription and delivery.
15 Mar, 2022 | 09:55h | UTCResistance exercise as a treatment for sarcopenia: prescription and delivery – Age and Ageing
Extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: a pocket guide for radiologists.
15 Mar, 2022 | 09:51h | UTC
Caring for older adults during the COVID-19 pandemic.
15 Mar, 2022 | 09:48h | UTCCaring for older adults during the COVID-19 pandemic – Clinical Microbiology and Infection
Retrospective Cohort: Asthma in children and adolescents is not associated with increased risk of SARS-CoV-2 infection.
15 Mar, 2022 | 08:55h | UTCAsthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents – Pediatrics
Commentary: Kids with asthma not at higher risk of COVID-19, study finds – CIDRAP
Related:
We expected people with asthma to fare worse during COVID. Turns out they’ve had a break.
Asthma in COVID-19 hospitalizations: An overestimated risk factor?
Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease.
15 Mar, 2022 | 08:49h | UTC
Commentary on Twitter
NEW Research—LMICs account for more than 3/4 of global #COPD cases. W/ increased life expectancy in the majority of LMICs, prevalence of COPD in these countries is set to increase.
Study from NIHR @RESPIREGlobal Respiratory Health Unit https://t.co/KD1OSHuMAr pic.twitter.com/Mfm1uJ2tBm
— The Lancet Respiratory Medicine (@LancetRespirMed) March 11, 2022
Two years later, coronavirus evolution still surprises experts. Here’s why.
15 Mar, 2022 | 08:52h | UTCTwo years later, coronavirus evolution still surprises experts. Here’s why. – National Geographic
‘We suppressed our scientific imagination’: four experts examine the big successes and failures of the COVID response so far.
15 Mar, 2022 | 08:47h | UTC
Effectiveness of contact tracing in the control of infectious diseases: a systematic review.
14 Mar, 2022 | 01:45h | UTC
Meta-analysis of randomized controlled trials comparing intraoperative red blood cell transfusion strategies.
14 Mar, 2022 | 01:47h | UTCRelated:
Research: Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery
Transfusion Requirements After Cardiac Surgery: The TRACS Randomized Controlled Trial – JAMA
The changing epidemiology of SARS-CoV-2.
14 Mar, 2022 | 01:37h | UTCThe changing epidemiology of SARS-CoV-2 – Science
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
14 Mar, 2022 | 01:44h | UTCCommentaries:
Waning of COVID-19 vaccine effectiveness: individual and public health risk – The Lancet
Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
14 Mar, 2022 | 01:38h | UTCStopping pandemics before they start: Lessons learned from SARS-CoV-2 – Science
Writing up your clinical trial report for a scientific journal: the REPORT trial guide for effective and transparent research reporting without spin.
14 Mar, 2022 | 01:32h | UTC
Review: Post-acute COVID-19 syndrome.
14 Mar, 2022 | 01:34h | UTCPost-acute COVID-19 syndrome – European Respiratory Journal
Related:
ESCMID rapid guidelines for assessment and management of long COVID.
ERS statement on Long COVID-19 follow-up.
Proposed subtypes of long-Covid and their respective potential therapies.
EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.
Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Comprehensive quality of life outcomes with invasive vs. conservative management of chronic coronary disease in the ISCHEMIA trial.
14 Mar, 2022 | 01:27h | UTCComprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA – Circulation (link to abstract – $ for full-text)
Original Articles:
ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease
ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
Commentary on Twitter
#OriginalResearch: Analysis from the #ISCHEMIA trial showed that chronic #CAD patients with frequent baseline angina reported improvement in QoL when treated with invasive strategy vs conservative management @djc795 @greggwstone @sripalbangalor @DanMarkMD https://t.co/mC8ey8qUCx pic.twitter.com/jF5SiaKdV0
— Circulation (@CircAHA) March 10, 2022
Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease.
14 Mar, 2022 | 01:25h | UTC
Cohort Study: Long-term cannabis use is associated with cognitive deficits and smaller hippocampal volume in midlife.
14 Mar, 2022 | 01:31h | UTCLong-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife – The American Journal of Psychiatry (link to abstract – $ for full-text)
Commentary: Long-Term Cannabis Use Associated With Cognitive Deficits in Midlife – Psychiatric News Alert
RCT: Methenamine Hippurate (a non-antibiotic preventive treatment) is noninferior to prophylactic antibiotics for treating recurrent urinary tract infections in women.
11 Mar, 2022 | 10:21h | UTCNews Release: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom
Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ
Commentaries:
Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP
Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay
Commentary on Twitter
The antiseptic drug methenamine hippurate is as good as antibiotics for preventing recurrent urinary tract infections in women, finds this trial
Includes a visual abstract displaying the findings #BMJInfographic https://t.co/LJNx2OEKhO @chrisharding123 pic.twitter.com/CjxWtjao6r
— The BMJ (@bmj_latest) March 10, 2022
Systematic Review: Inhaled corticosteroids for the treatment of COVID‐19.
11 Mar, 2022 | 10:18h | UTCInhaled corticosteroids for the treatment of COVID‐19 – Cochrane Library
Related:
[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.
Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.
RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19
Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19
Commentary on Twitter (thread – click for more)
Are inhaled #corticosteroids an effective treatment for people with mild #COVID19?
New #systematicreview from @CochraneAirways looks at using this well established treatment for asthma & COPD as a #COVIDtreatment https://t.co/dxUtudHLiW 1/4 pic.twitter.com/4nUs56Xfsg— The Cochrane Library (@CochraneLibrary) March 9, 2022
WHO Guidance: Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing.
11 Mar, 2022 | 10:20h | UTC
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21.
11 Mar, 2022 | 10:16h | UTCCommentaries:
COVID’s true death toll: far higher than official records – Nature
Covid deaths probably three times higher than records say – BBC
Related:
Editorial: “Excess deaths” is the best metric for tracking the pandemic.
The pandemic’s true death toll: millions more than official counts.
Global Covid-19 deaths surpass five million.
Under-reporting of deaths limits our understanding of true burden of covid-19.
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Commentary on Twitter
? @TheLancet
This week it was widely announced we surpassed 6 million global Covid deaths.
The real number is likely more than 18 million, as determined by excess mortality at the end of 2021.https://t.co/VGHm5MID9i pic.twitter.com/DyYk6fLmWX— Eric Topol (@EricTopol) March 10, 2022
COVID pandemic 2nd anniversary: 3 things we got wrong, and 3 things to watch out for.
11 Mar, 2022 | 10:07h | UTC
Misinformation: susceptibility, spread, and interventions to immunize the public.
11 Mar, 2022 | 10:03h | UTCMisinformation: susceptibility, spread, and interventions to immunize the public – Nature Medicine
See also: An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy – Nature Medicine
Another study suggests that a third vaccine dose is necessary to protect populations against the omicron variant.
11 Mar, 2022 | 10:14h | UTCNews Release: Third vaccine dose critical for protecting populations against omicron variant – BMJ Newsroom
Commentary on Twitter
mRNA vaccines are highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. But three doses are needed to achieve a similar level of protection against omicron, finds a large US study: https://t.co/YMm176gmby
— The BMJ (@bmj_latest) March 10, 2022